Have a personal or library account? Click to login
Efficacy and safety of dulaglutide in patients with absolute insulin deficiency Cover

Efficacy and safety of dulaglutide in patients with absolute insulin deficiency

Endocrine Regulations
Volume 53 (2019): Issue 3 (July 2019)
By: Eiji Kutoh,  Jyunka Hayashi and  Alexandra N. Kuto  
Open Access
|Aug 2019
DOI: https://doi.org/10.2478/enr-2019-0019 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668
Journal RSS Feed
Language: English
Page range: 187 - 190
Published on: Aug 24, 2019
Published by: Slovak Academy of Sciences, Institute of Experimental Endocrinology
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
GLP-1 agonist,
dulaglutide,
type 1 diabetes,
insulin deficiency
Related subjects:
Life sciences,
Molecular biology,
Neurobiology,
Medicine,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Internal medicine,
Endocrinology, diabetology

© 2019 Eiji Kutoh, Jyunka Hayashi, Alexandra N. Kuto, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 53 (2019): Issue 3 (July 2019)Next article